EP Patent

EP4424363A2 — Methods for increasing growth in pediatric subjects having cholestatic liver disease

Assigned to Mirum Pharmaceuticals Inc · Expires 2024-09-04 · 2y expired

What this patent protects

Provided herein are methods for increasing growth in a pediatric subject having a cholestatic liver disease. The method includes administering to the subject an effective amount of an ASBTI.

USPTO Abstract

Provided herein are methods for increasing growth in a pediatric subject having a cholestatic liver disease. The method includes administering to the subject an effective amount of an ASBTI.

Drugs covered by this patent

Patent Metadata

Patent number
EP4424363A2
Jurisdiction
EP
Classification
—
Expires
2024-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Mirum Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.